Remix Therapeutics, a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced the appointment of...
Frontage Holdings Corporation ("Frontage") is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer ("CFO"), effective February 1, 2024. As CFO,...
EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform for full-spectrum microbiome therapeutics, announced the appointments of Dr James Barnes as...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, unveiled an alliance through which Personalis will...
